Charles River Laboratories International Inc (CRL)
233.47
+3.58
(+1.56%)
USD |
NYSE |
May 03, 16:00
233.40
-0.06
(-0.03%)
Pre-Market: 20:00
Charles River Laboratories International Cash from Operations (Quarterly): 220.94M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 220.94M |
September 30, 2023 | 205.45M |
June 30, 2023 | 148.12M |
March 31, 2023 | 109.38M |
December 31, 2022 | 234.76M |
September 30, 2022 | 132.78M |
June 30, 2022 | 149.47M |
March 31, 2022 | 102.63M |
December 31, 2021 | 229.26M |
September 30, 2021 | 174.72M |
June 30, 2021 | 186.59M |
March 31, 2021 | 170.23M |
December 31, 2020 | 138.38M |
September 30, 2020 | 177.30M |
June 30, 2020 | 162.31M |
March 31, 2020 | 68.59M |
December 31, 2019 | 180.68M |
September 30, 2019 | 155.85M |
June 30, 2019 | 129.55M |
March 31, 2019 | 14.86M |
December 31, 2018 | 139.97M |
September 30, 2018 | 117.24M |
June 30, 2018 | 123.87M |
March 31, 2018 | 60.05M |
December 31, 2017 | 124.24M |
Date | Value |
---|---|
September 30, 2017 | 59.48M |
June 30, 2017 | 100.80M |
March 31, 2017 | 33.56M |
December 31, 2016 | 120.08M |
September 30, 2016 | 71.64M |
June 30, 2016 | 79.82M |
March 31, 2016 | 45.36M |
December 31, 2015 | 120.33M |
September 30, 2015 | 87.95M |
June 30, 2015 | 85.74M |
March 31, 2015 | 10.94M |
December 31, 2014 | 99.34M |
September 30, 2014 | 66.96M |
June 30, 2014 | 56.95M |
March 31, 2014 | 27.80M |
December 31, 2013 | 62.12M |
September 30, 2013 | 67.02M |
June 30, 2013 | 48.02M |
March 31, 2013 | 29.97M |
December 31, 2012 | 64.51M |
September 30, 2012 | 60.83M |
June 30, 2012 | 57.28M |
March 31, 2012 | 25.28M |
December 31, 2011 | 72.04M |
September 30, 2011 | 48.29M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
68.59M
Minimum
Mar 2020
234.76M
Maximum
Dec 2022
161.95M
Average
162.31M
Median
Jun 2020
Cash from Operations (Quarterly) Benchmarks
Cardinal Health Inc | -49.00M |
Stryker Corp | 204.00M |
DaVita Inc | -134.84M |
IDEXX Laboratories Inc | 198.58M |
Medpace Holdings Inc | 152.68M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -238.37M |
Cash from Financing (Quarterly) | 123.57M |
Free Cash Flow | 365.37M |
Free Cash Flow Per Share (Quarterly) | 2.779 |
Free Cash Flow to Equity (Quarterly) | 9.69M |
Free Cash Flow to Firm (Quarterly) | 171.55M |
Free Cash Flow Yield | 3.04% |